Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses.
Front Immunol
; 14: 1182504, 2023.
Article
in En
| MEDLINE
| ID: mdl-37215095
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Common Cold
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2023
Document type:
Article
Affiliation country:
Germany
Country of publication:
Switzerland